Top Markets
Coin of the day
Arix Bioscience plc Arix Bioscience plc

Arix Bioscience plc

ARIX
Rank in Stocks #36613
Arix Bioscience plc operates as a venture capital firm, focusing its... Arix Bioscience plc operates as a venture capital firm, focusing its investments across the entire lifecycle of companies, from nascent seed-stage ventures and preclinical or clinical asset development to early, mid, and late-stage growth capital rounds, encompassing both private and public equity. The firm's investment mandate is global, targeting the biotechnology sector and seeking out entities involved in groundbreaking therapeutics, cutting-edge technologies, and broader medical innovations spanning healthcare and life sciences. Employing an evergreen funding model, Arix Bioscience predominantly deploys capital directly from its own balance sheet. It generally prefers to secure a board position within its portfolio companies and strategically exits investments once the peak value has been realized. Established in 2015 and headquartered in London, United Kingdom, the company was previously known as Perceptive Bioscience Investments Limited.
Share Price
$1.93
Last synced: 2024-02-09
Market Cap
$2.50M
Change (1 day)
6.72%
Change (1 year)
0.00%
Country
GB
Trade Arix Bioscience plc (ARIX)

Category

Number of shares outstanding for Arix Bioscience plc (ARIX)
Number of shares outstanding as of August 2026: 0
According to Arix Bioscience plc latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Arix Bioscience plc (ARIX) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
253.90M -
US
62.19M -
NL
- -
CH
- -
KR
0.00 -
BE